Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201210128 Principal Investigator: Bartlett, Nancy
Title: A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma (C25003)
Phase: III Disease Site: Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to compare how well two different treatments work. In this study, patients will receive either a treatment that includes the investigational drug called brentuximab vedotin or a commonly prescribed treatment that does not contain brentuximab vedotin.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)